Inogen, Inc.

Equities

INGN

US45780L1044

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
6.78 ^USD	+4.63%		+0.44%	+23.50%

Feb. 28	Top Midday Decliners	MT
Feb. 28	Top Premarket Decliners	MT

Inogen, Inc. Provides Earnings Guidance for the First Quarter 2024

February 27, 2024 at 04:09 pm EST

Inogen, Inc. provided earnings guidance for the first quarter 2024. For the period, the company expects revenue of $73 to $74 million, reflecting 1% to 3% reported growth relative to the first quarter 2023.

Latest news about Inogen, Inc.

Top Midday Decliners	Feb. 28	MT
Top Premarket Decliners	Feb. 28	MT
Transcript : Inogen, Inc., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Earnings Flash (INGN) INOGEN Posts Q4 Revenue $75.9M, vs. Street Est of $77M	Feb. 27	MT
Inogen, Inc. Provides Earnings Guidance for the First Quarter 2024	Feb. 27	CI
Inogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Inogen, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
North American Morning Briefing : S&P 500 Seen -2-	Feb. 16	DJ
Sector Update: Health Care Stocks Higher Late Afternoon	Feb. 15	MT
Sector Update: Health Care	Feb. 15	MT
Inogen Shares Rise After Upgrade From William Blair	Feb. 15	MT
William Blair Upgrades Inogen to Outperform From Market Perform	Feb. 15	MT
Inogen Names Michael Bourque as Finance Chief	Jan. 25	MT
Inogen, Inc. Announces CFO Changes, Effective March 4, 2024	Jan. 24	CI
Inogen, Inc. Announces Executive Changes, Effective March 4, 2024	Jan. 24	CI
North American Morning Briefing : Boeing Drags Down Dow Futures	Jan. 08	DJ
Inogen Appoints Gregoire Ramade as Chief Commercial Officer; Shares Rise	Jan. 05	MT
Inogen, Inc. Appoints Grgoire Ramade to Serve as Chief Commercial Officer	Jan. 05	CI
Inogen, Inc. Announces Separation Agreement with Nabil Shabshab	Nov. 27	CI
Inogen Appoints Kevin Smith as Chief Executive	Nov. 13	MT
Inogen Announces Board Changes	Nov. 13	CI
Inogen Announces CEO Changes	Nov. 13	CI
Transcript : Inogen, Inc., Q3 2023 Earnings Call, Nov 07, 2023	Nov. 07
Earnings Flash (INGN) INOGEN Reports Q3 Revenue $84M, vs. Street Est of $82.1M	Nov. 07	MT
Inogen, Inc. Provides Earnings Guidance for the Fiscal Year 2023	Nov. 07	CI

Chart Inogen, Inc.

Duration

Period

More charts

Company Profile

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-06 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Inogen, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

6.78 USD

Average target price

6.5 USD

Spread / Average Target

-4.13%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
INOGEN, INC.	+23.50%	160M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution